Michael Naughton MD in Sikeston, Missouri

Home Missouri Sikeston

Michael Naughton MD has Medical Oncology as his primary medical specialty. Their primary office is: 1126 N Main St in Sikeston, Missouri. There is an additional office location, for a total of two, for Michael Naughton MD that can be viewed further down.

They're a part of the: Missouri Delta Medical Center medical group which has around 71 members. You can call their office at 573-471-4312 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended State University Of New York At Buffalo School Of Medicine and graduated in 1993 (around 31 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michael J Naughton MD Office Phone and Directions

Michael Naughton MD
Missouri Delta Medical Center
1126 N Main St
Sikeston, Missouri 63801
573-471-4312

Patient Ratings
Please rate your experience with Michael Naughton MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 573-471-4312

Enter a starting address:

Healthcare Info for Michael Naughton MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: State University Of New York At Buffalo School Of Medicine
Graduation Year: 1993
The Primary Medical Specialty for Michael Naughton MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 9234173303
NPI #: 1295752830
NPI Created On: 07/17/2006
NPI Last Updated Listed as: 02/24/2021
Primary Taxonomy Code: 207RX0202X
License Number:
103671
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 30 minutes per day
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $65

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788086139

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788086141

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788086143

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781447703

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CINV

Name of Drug #1: Cinvanti

Open Associated Drug #1: 47426-201-01

Payments Total: $34

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781447881

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CINV

Name of Drug #1: Cinvanti

Open Associated Drug #1: 47426-201-01

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781453189

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CINV

Name of Drug #1: Cinvanti

Open Associated Drug #1: 47426-201-01

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017459

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795296892

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795296899

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795296905

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Additional Office Locations

1. Saint Francis Medical Center
211 Saint Francis Dr
Cape Girardeau, MO 63703
Suite 372
Group Members: 377

Phone: 573-471-4312

Enter a starting address:

Providers in Missouri Delta Medical Center

1.Muhannad Al-kilani

1118 N Main St
Sikeston Mo 63801-5046
Missouri Delta Medical Center
Endocrinology

2.Muhannad Al-kilani

1008 N Main St
Sikeston Mo 63801-5099
Missouri Delta Medical Center
Endocrinology

3.Rami Alassaad

1008 N Main St
Sikeston Mo 63801-5099
Missouri Delta Medical Center
Internal Medicine

4.Luis Arcay Montagne

1008 N Main St
Sikeston Mo 63801-5099
Missouri Delta Medical Center
Internal Medicine

5.Kayla Babb-dicus

1017 N Main St
Sikeston Mo 63801-5043
Missouri Delta Medical Center
Nurse Practitioner

6.Kayla Babb-dicus

1019 N Main St
Sikeston Mo 63801-5043
Missouri Delta Medical Center
Nurse Practitioner

View all 71 members of Missouri Delta Medical Center medical group